2026 Q3 Portfolio Activity
In 2026 Q3, Kalehua Capital Management LLC maintained a portfolio of 32 distinct positions. The most significant new addition was EA SERIES TRUST, now representing 13.28% of the total fund value. They heavily accumulated shares in MILESTONE PHARMACEUTICALS IN, increasing the position by 30.1%. Conversely, Kalehua Capital Management LLC completely exited their position in Compass Pathways Plc.
Position History
hover any row below to update
Loading…
Total Positions
32
Quarter
2026 Q3
Top Holding
MANE (13.3%)
Top 10 Concentration
80.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-32 of 32
Kalehua Capital Management LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MANE
VERADERMICS INC
|
Healthcare | 13.34% | 12.84% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
145,695 | $17,662,605 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
BOXX
EA SERIES TRUST
|
Unknown | 13.28% | — |
#2
Prev: #—
|
9.0 |
—
|
148,471 | — |
NEW
|
148,471 | $17,577,482 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KRSA
KORSANA BIOSCIE...
|
Healthcare | 10.70% | — |
#3
Prev: #—
|
8.5 |
—
|
442,653 | — |
NEW
|
442,653 | $14,164,896 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
XFOR
X4 PHARMACEUTIC...
|
Healthcare | 8.15% | 12.46% |
#4
2
Prev: #2
|
4.8 |
—
|
no change | no change |
P
S
|
3,722,840 | $10,796,236 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ACRS
ACLARIS THERAPE...
|
Healthcare | 7.28% | 6.95% |
#5
Prev: #5
|
4.4 |
—
|
no change | no change |
P
S
|
1,832,365 | $9,638,240 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SRZN
SURROZEN INC
|
Healthcare | 6.95% | 7.16% |
#6
2
Prev: #4
|
2.8 |
—
|
-99,086 | -25.7% |
P
S
|
286,092 | $9,206,441 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 5.93% | 5.56% |
#7
Prev: #7
|
3.4 |
—
|
no change | no change |
P
S
|
3,821,890 | $7,853,984 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SEPN
SEPTERNA INC
|
Healthcare | 5.75% | 4.67% |
#8
2
Prev: #10
|
3.3 |
—
|
no change | no change |
P
S
|
194,544 | $7,612,507 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
BETRF
BETTERLIFE PHAR...
|
Healthcare | 5.04% | — |
#9
Prev: #—
|
5.5 |
—
|
27,710,000 | — |
NEW
|
27,710,000 | $6,675,339 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
OBX
OBSIDIAN THERAP...
|
Healthcare | 4.32% | — |
#10
Prev: #—
|
5.2 |
—
|
416,649 | — |
NEW
|
416,649 | $5,720,591 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IFRX
INFLARX NV
|
Healthcare | 3.97% | 4.65% |
#11
Prev: #11
|
2.1 |
—
|
23,326 | 0.8% |
P
S
|
2,921,095 | $5,257,971 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KRRO
KORRO BIO, INC
|
Healthcare | 3.54% | — |
#12
Prev: #—
|
4.9 |
—
|
473,595 | — |
NEW
|
473,595 | $4,693,326 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
N/A
ATTOVIA THERAPE...
|
|
Unknown | 2.59% | — |
#13
Prev: #—
|
4.5 |
—
|
200,000 | — |
NEW
|
200,000 | $3,428,000 | — | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
N/A
DAMORA THERAPEU...
|
|
Unknown | 2.23% | — |
#14
Prev: #—
|
4.4 |
—
|
139,000 | — |
NEW
|
139,000 | $2,957,920 | — | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
QURE
UNIQURE NV
|
Healthcare | 1.45% | 2.62% |
#15
2
Prev: #13
|
1.6 |
—
|
no change | no change |
P
S
|
79,407 | $1,918,473 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
GOSS
GOSSAMER BIO IN...
|
Healthcare | 1.25% | 1.32% |
#16
3
Prev: #19
|
0.5 |
—
|
-11,009,997 | -98.8% |
P
S
|
139,366 | $1,651,487 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
MIST
MILESTONE PHARM...
|
Healthcare | 1.08% | 1.22% |
#17
3
Prev: #20
|
2.9 |
—
|
382,021 | 30.1% |
P
S
|
1,651,258 | $1,429,494 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
LONA
LEONABIO INC
|
Healthcare | 1.06% | 2.59% |
#18
4
Prev: #14
|
1.4 |
—
|
no change | no change |
P
S
|
393,701 | $1,405,513 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
N/A
ATRIUM THERAPEU...
|
|
Unknown | 0.70% | — |
#19
Prev: #—
|
3.8 |
—
|
112,652 | — |
NEW
|
112,652 | $932,759 | — | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
TIL
INSTIL BIO INC
|
Healthcare | 0.54% | 0.55% |
#20
2
Prev: #22
|
1.2 |
—
|
no change | no change |
P
S
|
99,600 | $721,104 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ATYR
ATYR PHARMA INC
|
Healthcare | 0.42% | 0.76% |
#21
Prev: #21
|
0.7 |
—
|
41,346 | 2.3% |
P
S
|
1,829,513 | $554,342 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KZIA
KAZIA THERAPEUT...
|
Healthcare | 0.41% | — |
#22
Prev: #—
|
3.7 |
—
|
56,013 | — |
NEW
|
56,013 | $537,445 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TCRX
Tscan Therapeut...
|
Healthcare | 0.00% | 0.32% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-454,876 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NVCT
Nuvectis Pharma...
|
Healthcare | 0.00% | 1.32% |
Sold All 😨
(Was: #18) |
0.0 |
—
|
-100,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TYRA
Tyra Bioscience...
|
Healthcare | 0.00% | 1.70% |
Sold All 😨
(Was: #17) |
0.0 |
—
|
-74,465 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
MLTX
MoonLake Immuno...
|
Healthcare | 0.00% | 2.45% |
Sold All 😨
(Was: #16) |
0.0 |
—
|
-175,734 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
GLTO
Damora Therapeu...
|
Healthcare | 0.00% | 2.59% |
Sold All 😨
(Was: #15) |
0.0 |
—
|
-139,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CYCN
Cyclerion Thera...
|
Healthcare | 0.00% | 4.01% |
Sold All 😨
(Was: #12) |
0.0 |
—
|
-1,651,350 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KPTI
Karyopharm Ther...
|
Healthcare | 0.00% | 4.80% |
Sold All 😨
(Was: #9) |
0.0 |
—
|
-685,644 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PHVS
Pharvaris NV
|
Healthcare | 0.00% | 4.93% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-198,772 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SION
Sionna Therapeu...
|
Healthcare | 0.00% | 6.21% |
Sold All 😨
(Was: #6) |
0.0 |
—
|
-197,072 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CMPS
Compass Pathway...
|
Healthcare | 0.00% | 8.31% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-819,692 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 |
Showing 1-32 of 32 holdings